Have a personal or library account? Click to login
A prospective pilot study of kidney-specific biomarkers to detect acute kidney injury after cytoreduction and hyperthermic intraperitoneal chemotherapy Cover

A prospective pilot study of kidney-specific biomarkers to detect acute kidney injury after cytoreduction and hyperthermic intraperitoneal chemotherapy

Open Access
|Dec 2024

References

  1. Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat Rev. 2016; 48:42–9.
  2. Chen CY, Chang HY, Lu CH, Chen MC, Huang TH, Lee LW, et al. Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2020; 37:1279–86.
  3. Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014; 371:58–66.
  4. Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014; 9:12–20.
  5. Schiffl H, Lang SM. Update on biomarkers of acute kidney injury: moving closer to clinical impact? Mol Diag Ther. 2012; 16:199–207.
  6. Albert C, Zapf A, Haase M, Röver C, Pickering JW, Albert A, et al. Neutrophil gelatinase-associated lipocalin measured on clinical laboratory platforms for the prediction of acute kidney injury and the associated need for dialysis therapy: a systematic review and meta-analysis. Am J Kidney Dis. 2020; 76:826–41.e1. doi: 10.1053/j.ajkd.2020.05.015
  7. Ye Z, Liu H, Zhao B, Fu H, Li Y, Chen L. Correlation and diagnostic value of serum Cys-C, RBP4, and NGAL with the condition of patients with traumatic acute kidney injury. Evid Based Complement Alternat Med. 2021; 2021:4990941. doi: 10.1155/2021/4990941
  8. Hei ZQ, Li XY, Shen N, Pang HY, Zhou SL, Guan JQ. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation. Chin Med J (Engl). 2008; 121:1251–6.
  9. Song Y, Kim DH, Kwon TD, Han DW, Baik SH, Jung HH, et al. Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial. Int J Hyperthermia. 2019; 36:1–8.
  10. Bouhadjari N, Gabato W, Calabrese D, Msika S, Keita H. Hyperthermic intraperitoneal chemotherapy with cisplatin: amifostine prevents acute severe renal impairment. Eur J Surg Oncol. 2016; 42:219–23.
  11. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8:R204–12.
  12. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD Group. STARD 2015: an Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. Clin Chem. 2015; 61:1446–52.
  13. de Geus HR, Betjes MG, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J. 2012; 5:102–8.
  14. Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH. Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res. 2017; 9:259–66.
  15. Wang R, Hu H, Hu S, He H, Shui H. beta2-microglobulin is an independent indicator of acute kidney injury and outcomes in patients with intracerebral hemorrhage. Medicine (Baltimore). 2020; 99:e19212. doi: 10.1097/MD.0000000000019212
  16. Ahmad T, Jackson K, Rao VS, Tang WHW, Brisco-Bacik MA, Chen HH, et al. Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation. 2018; 137:2016–28.
  17. Ozkok A, Edelstein CL. Pathophysiology of cisplatin-induced acute kidney injury. Biomed Res Int. 2014; 2014:967826. doi: 10.1155/2014/967826
  18. Kellum JA, Ronco C, Bellomo R. Conceptual advances and evolving terminology in acute kidney disease. Nat Rev Nephrol. 2021; 17:493–502.
  19. Lumlertgul N, Ostermann M, McCorkell S, van Dellen J, Williams AB. Association of plasma and urine NGAL with acute kidney injury after elective colorectal surgery: a cohort study. Ann Med Surg (Lond). 2021; 62:315–22.
  20. Arjona-Sánchez A, Cadenas-Febres A, Cabrera-Bermon J, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, et al. Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances. Eur J Surg Oncol. 2016; 42:869–76.
DOI: https://doi.org/10.2478/abm-2024-0034 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 268 - 280
Published on: Dec 16, 2024
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2024 Chao-Yu Chen, Ting-Yao Wang, Hung-Yu Chang, Min-Chi Chen, Lan-Yan Yang, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.